Semaglutide drugs, such as Wegovy, are commonly used to treat type 2 diabetes by helping with blood sugar management and weight loss. These drugs are GLP-1 receptor agonists that work by increasing insulin production and suppressing appetite. Wegovy is the only semaglutide drug approved for weight management in individuals with overweight and obesity in the United States and the United Kingdom. However, some people on Wegovy report hitting a weight loss plateau that they struggle to overcome. Dr. Simon Cork, a senior lecturer at Anglia Ruskin University, helps shed light on how semaglutide aids in weight management, why some individuals hit a weight loss plateau, and important considerations when using semaglutide for weight loss.
Semaglutide drugs like Wegovy are effective in managing blood sugar levels by increasing insulin production and promoting weight loss by reducing appetite. Although Wegovy is approved for weight management in individuals with overweight and obesity, many users experience a weight loss plateau that can be challenging to overcome. Dr. Simon Cork explains how semaglutide works to help with weight management and discusses common issues that may arise when using semaglutide for weight loss. He provides insights on why some people hit a weight loss plateau on Wegovy and offers advice on how to break past this plateau.
Semaglutide drugs, such as Wegovy, are beneficial in treating type 2 diabetes and aiding in weight management. These drugs work by increasing insulin production and suppressing appetite, leading to weight loss in individuals with overweight and obesity. However, some individuals on Wegovy experience a weight loss plateau that can be difficult to overcome. Dr. Simon Cork, a senior lecturer at Anglia Ruskin University, discusses the mechanisms of semaglutide in weight management and addresses common issues that may arise, such as hitting a weight loss plateau. He provides valuable insights on how to break past a weight loss plateau while using semaglutide for weight loss.
Semaglutide drugs, including Wegovy, are commonly prescribed for individuals with type 2 diabetes to manage blood sugar levels and aid in weight loss by reducing appetite. Wegovy is approved as a weight management aid for individuals with overweight and obesity, but some users report hitting a plateau in their weight loss journey. Dr. Simon Cork, a senior lecturer at Anglia Ruskin University, explains how semaglutide drugs work to help with weight management and addresses common issues such as hitting a weight loss plateau. He offers valuable advice on how to overcome a weight loss plateau while using semaglutide for weight loss.
Semaglutide drugs like Wegovy are commonly used to treat type 2 diabetes and aid in weight management by increasing insulin production and suppressing appetite. Although Wegovy is approved for weight management in individuals with overweight and obesity, some users experience difficulty in overcoming a weight loss plateau. Dr. Simon Cork, a senior lecturer at Anglia Ruskin University, provides insights on the mechanisms of semaglutide in weight management and discusses common issues related to hitting a weight loss plateau. He offers advice on how to break past a weight loss plateau while using semaglutide for weight loss.
Semaglutide drugs, such as Wegovy, are widely used to treat type 2 diabetes and aid in weight management by increasing insulin production and suppressing appetite. Although Wegovy is approved for weight management in individuals with overweight and obesity, some users encounter a weight loss plateau that can be challenging to overcome. Dr. Simon Cork, a senior lecturer at Anglia Ruskin University, discusses how semaglutide drugs work to help with weight management and addresses common issues like hitting a weight loss plateau. He offers valuable advice on how to overcome a weight loss plateau while using semaglutide for weight management.